HIV/AIDS News and Research

RSS

Acquired immune deficiency syndrome or acquired immunodeficiency syndrome (AIDS) is a disease of the human immune system caused by the human immunodeficiency virus (HIV).

Mylan launches Risedronate Sodium Tablets USP, 150 mg

Mylan Inc. today announced that it has launched Risedronate Sodium Tablets USP, 150 mg, the generic version of Warner Chilcott's Actonel Tablets. Mylan received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application (ANDA) for this product, which is indicated for the treatment and prevention of osteoporosis in postmenopausal women.

11 Jun 2014

AHF welcomes passage of new HIV transmission bill

Marking the first change in state health code regarding HIV transmission in nearly a decade, Iowa Governor Terry E. Branstad signed a landmark bill on May 30 that will curb rampant convictions of people living with HIV for transmitting the virus by redefining the law to ensure only those who intend to spread HIV or behave with "reckless disregard" are penalized.

11 Jun 2014

Adding evidence-based weight loss strategies enhances statewide wellness campaign

Researchers from The Miriam Hospital have found that adding evidence-based weight loss strategies to a statewide wellness campaign improves weight loss outcomes among participants. The study and its findings are published online in advance of print in the American Journal of Public Health.

11 Jun 2014

Mylan launches generic version of Bristol-Myers Squibb's Paraplatin Injection

Mylan Inc. today announced that it has launched Carboplatin Injection, 50 mg/5 ml, in multi-dose vials, which is the generic version of Bristol-Myers Squibb's Paraplatin® Injection.

9 Jun 2014

Disinfection caps reduce CLABSI events by 68%

Thanks to the simple use of an alcohol-impregnated cap, Loyola University Medical Center achieved a 68 percent decrease in the overall number of central line-associated bloodstream infections (CLABSI) over a 12-month period.

5 Jun 2014

Loyola achieves 68% decrease in central line-associated bloodstream infections

Loyola University Medical Center achieved a 68 percent decrease in the overall number of central line-associated bloodstream infections (CLABSI) over a 12-month period. A two-year study compared the use of disinfection caps to an intense scrub-the-hub intervention to standard care. Scrub-the-hub refers to cleaning catheter connector hubs and injection ports with alcohol for the recommended 15 seconds before accessing the central line, a catheter placed in a large vein to deliver medicine and liquids during hospitalization.

5 Jun 2014

CIRM grants $5.6 million to develop HIV/AIDS therapeutic using Sangamo's ZFN genome-editing technology

Sangamo BioSciences, Inc. announced that the California Institute for Regenerative Medicine (CIRM) has granted a $5.6 million Strategic Partnership Award to fund clinical studies at City of Hope to develop a potentially curative ZFP Therapeutic for HIV/AIDS based on the application of Sangamo's zinc finger nuclease (ZFN) genome-editing technology in hematopoietic stem/progenitor cells (HSPCs).

31 May 2014

State highlights: Complaint says Fla. plans tried to keep out AIDS patients; Ill. restores some Medicaid services; Fla. Gov. to sue feds

Four Florida insurance companies offering Affordable Care Act policies are discriminating against people with HIV or AIDS, according to two health-rights organizations that plan to file a formal complaint with the federal government Thursday.

30 May 2014

New approach could lead to more effective HIV vaccine

Using a genetically modified form of the HIV virus, a team of University of Nebraska-Lincoln scientists has developed a promising new approach that could someday lead to a more effective HIV vaccine.

30 May 2014

Mylan launches generic version of GlaxoSmithKline's Malarone Tablets

Mylan Inc. today announced that it has launched Atovaquone and Proguanil Hydrochloride Tablets, 62.5 mg/25 mg and 250 mg/100 mg, the generic version of GlaxoSmithKline's Malarone® Tablets.

29 May 2014

BioTime receives ISO 13485:2003 certification for development of BioTime HyStem hydrogels

BioTime, Inc. today announced that it has received ISO 13485:2003 certification from BSI (British Standards Institution) for design, development, manufacture, and distribution of BioTime HyStem® hydrogels for cell delivery applications.

28 May 2014

Study: Children born with HIV more likely to develop resistance to antiretroviral drugs than adults

Children born with HIV are far more likely to develop resistance to antiretroviral drugs than adults, according to a new Tulane University School of Medicine study.

23 May 2014

Viewpoints: Cutting costs for patients with chronic illness; Gov. Pence's change of Heart; fix the VA

Most health care plans ask that you spend some money out of your pocket whenever you use the health care system. This is known as cost-sharing .... Cost-sharing works for most people, because most people are healthy. Healthy people who use health care are often doing so inefficiently.

21 May 2014

Three scientists selected to receive NIDA's 2014 Avant-Garde Award for HIV/AIDS Research

With proposals ranging from enhancing the immune system's ability to fight HIV infection to improving long-term immune health in HIV-infected drug users, three scientists have been chosen to receive the 2014 Avant-Garde Award for HIV/AIDS Research from the National Institute on Drug Abuse, part of the National Institutes of Health.

19 May 2014

DNA-directed RNA interference and hepatitis C: an interview with Carl Stubbings, Chief Business Officer, Benitec Biopharma

RNA interference (RNAi) is a naturally occurring process, which cells can use to silence, or ‘turn off’ unwanted genes.

From Quest Diagnostics 19 May 2014

IAVI: Together, we can achieve a world without AIDS

Do you remember the world before HIV/AIDS? Where will you be when the shadow of this disease is finally gone?

19 May 2014

Specific Technologies unveils SpecID blood culture system at General Meeting of the American Society for Microbiology

Specific Technologies, developer of the SpecID™ system to rapidly detect and identify bacterial species and strain via a metabolomic fingerprint, today announced that for the first time it will showcase its transformative SpecID blood culture system at the 114th General Meeting of the American Society for Microbiology, May 17-20, 2014 in Boston, Massachusetts at the Boston Convention and Exhibition Center.

16 May 2014

20th International AIDS Conference calls for end to discrimination against HIV patients

A declaration affirming that non-discrimination is fundamental to an evidence-based response to HIV and effective public health programmes was announced today by the organizers of the 20th International AIDS Conference (AIDS 2014), to be held in Melbourne, Australia, from 20-25 July 2014.

16 May 2014

Study led by TSRI scientists likely to influence future designs for HIV vaccines, antibody-based therapies

A vaccine or other therapy directed at a single site on a surface protein of HIV could in principle neutralize nearly all strains of the virus—thanks to the diversity of targets the site presents to the human immune system.

16 May 2014

Depression is the leading cause of illness in adolescents, shows WHO's report

WHO's "Health for the world's adolescents" report reveals that depression is the predominant cause of illness and disability for both boys and girls aged 10 to 19 years.

15 May 2014

HIV/AIDS News and Research

Further Reading

Mylan launches Risedronate Sodium Tablets USP, 150 mg

AHF welcomes passage of new HIV transmission bill

Adding evidence-based weight loss strategies enhances statewide wellness campaign

Mylan launches generic version of Bristol-Myers Squibb's Paraplatin Injection

Disinfection caps reduce CLABSI events by 68%

Loyola achieves 68% decrease in central line-associated bloodstream infections

CIRM grants $5.6 million to develop HIV/AIDS therapeutic using Sangamo's ZFN genome-editing technology

State highlights: Complaint says Fla. plans tried to keep out AIDS patients; Ill. restores some Medicaid services; Fla. Gov. to sue feds

New approach could lead to more effective HIV vaccine

Mylan launches generic version of GlaxoSmithKline's Malarone Tablets

BioTime receives ISO 13485:2003 certification for development of BioTime HyStem hydrogels

Study: Children born with HIV more likely to develop resistance to antiretroviral drugs than adults

Viewpoints: Cutting costs for patients with chronic illness; Gov. Pence's change of Heart; fix the VA

Three scientists selected to receive NIDA's 2014 Avant-Garde Award for HIV/AIDS Research

DNA-directed RNA interference and hepatitis C: an interview with Carl Stubbings, Chief Business Officer, Benitec Biopharma

IAVI: Together, we can achieve a world without AIDS

Specific Technologies unveils SpecID blood culture system at General Meeting of the American Society for Microbiology

20th International AIDS Conference calls for end to discrimination against HIV patients

Study led by TSRI scientists likely to influence future designs for HIV vaccines, antibody-based therapies

Depression is the leading cause of illness in adolescents, shows WHO's report

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News